Barclays’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-400,000
Closed -$61.9M 5492
2025
Q4
$61.9M Buy
+400,000
New +$59.9M 0.01% 676
2024
Q2
Sell
-400,000
Closed -$59.1M 5361
2024
Q1
$59.1M Buy
+400,000
New +$57.4M 0.02% 555
2023
Q1
Sell
-8,000
Closed -$1.09M 5391
2022
Q4
$1.09M Buy
+8,000
New +$1.06M ﹤0.01% 2720
2021
Q1
Sell
-146,400
Closed -$16.6M 5270
2020
Q4
$16.6M Sell
146,400
-4,800
-3% -$524K 0.01% 911
2020
Q3
$15.9M Buy
151,200
+144,700
+2,226% +$15.2M 0.01% 843
2020
Q2
$650K Sell
6,500
-65,000
-91% -$6.42M ﹤0.01% 3122
2020
Q1
$6.33M Sell
71,500
-64,300
-47% -$6.25M 0.01% 1287
2019
Q4
$13.8M Buy
135,800
+72,100
+113% +$6.93M 0.01% 1177
2019
Q3
$5.74M Buy
63,700
+14,700
+30% +$1.34M ﹤0.01% 1727
2019
Q2
$4.54M Sell
49,000
-110,000
-69% -$9.89M ﹤0.01% 1956
2019
Q1
$14.6M Sell
159,000
-33,800
-18% -$3.05M 0.01% 1008
2018
Q4
$16.7M Buy
192,800
+118,700
+160% +$10.7M 0.01% 840
2018
Q3
$7.05M Sell
74,100
-95,800
-56% -$8.65M ﹤0.01% 1497
2018
Q2
$14.2M Sell
169,900
-78,000
-31% -$6.46M 0.01% 996
2018
Q1
$20.2M Sell
247,900
-124,600
-33% -$10.6M 0.02% 840
2017
Q4
$30.8M Buy
372,500
+103,000
+38% +$8.49M 0.03% 593
2017
Q3
$22M Sell
269,500
-448,700
-62% -$36M 0.02% 621
2017
Q2
$56.9M Buy
718,200
+577,300
+410% +$44M 0.06% 245
2017
Q1
$10.5M Sell
140,900
-225,800
-62% -$16.5M 0.01% 848
2016
Q4
$25.3M Buy
366,700
+234,600
+178% +$16.3M 0.03% 500
2016
Q3
$9.53M Sell
132,100
-124,600
-49% -$9.17M 0.01% 900
2016
Q2
$18.4M Buy
256,700
+28,700
+13% +$2.02M 0.02% 553
2016
Q1
$15.3M Buy
228,000
+169,200
+288% +$11.3M 0.02% 584
2015
Q4
$4.23M Sell
58,800
-110,800
-65% -$7.83M 0.01% 1440
2015
Q3
$11.2M Buy
169,600
+85,400
+101% +$6.24M 0.01% 871
2015
Q2
$6.23M Sell
84,200
-22,600
-21% -$1.67M 0.01% 1333
2015
Q1
$7.69M Sell
106,800
-252,000
-70% -$18M 0.01% 1246
2014
Q4
$24.4M Buy
358,800
+65,100
+22% +$4.36M 0.02% 661
2014
Q3
$18.5M Buy
293,700
+246,900
+528% +$15.5M 0.02% 763
2014
Q2
$2.81M Sell
46,800
-1,799,300
-97% -$106M ﹤0.01% 2273
2014
Q1
$107M Buy
1,846,100
+1,750,000
+1,821% +$101M 0.12% 139
2013
Q4
$5.29M Sell
96,100
-99,700
-51% -$5.33M 0.01% 1786
2013
Q3
$9.79M Sell
195,800
-171,400
-47% -$8.61M 0.01% 1158
2013
Q2
$17.5M Buy
+367,200
New +$17.6M 0.02% 716

Other funds holding XLV

Barclays's XLV Position: Q1 2026 in Review

Barclays increased its State Street Health Care Select Sector SPDR ETF (XLV) stake by 103% in Q1 2026, buying an estimated $152M and bringing the position to 1,947,906 shares worth $286M. The position accounts for 0.07% of the portfolio, ranked #208.

Barclays first reported a position in XLV in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.56B in Q4 2021. 1,804 funds tracked by Wall St. Rank hold XLV as of Q1 2026.

  • Barclays held 1,947,906 shares of State Street Health Care Select Sector SPDR ETF worth $286M as of Q1 2026.
  • Barclays bought 987,912 State Street Health Care Select Sector SPDR ETF shares in Q1 2026, an estimated $152M.
  • State Street Health Care Select Sector SPDR ETF made up 0.07% of Barclays's portfolio in Q1 2026, its #208 holding.
  • Barclays first reported a position in State Street Health Care Select Sector SPDR ETF in Q2 2013 and has held it in 52 quarters since.
  • Barclays's State Street Health Care Select Sector SPDR ETF position peaked at $1.56B in Q4 2021.
  • 1,804 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.